Sodium glucose co-transporter 2 inhibitors in heart failure therapy
Saved in:
Main Authors: | Yüksel Çavuşoğlu (Author), Hakan Altay (Author), Avivit Cahn (Author), Ahmet Celik (Author), Serafettin Demir (Author), Barış Kılıçaslan (Author), Sanem Nalbantgil (Author), Itamar Raz (Author), Ahmet Temizhan (Author), Özlem Yıldırımtürk (Author), Mehmet Birhan Yılmaz (Author) |
---|---|
Format: | Book |
Published: |
KARE Publishing,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of Hyperkalemia in Heart Failure
by: Hakan Altay, et al.
Published: (2021) -
Vaccination of adults with heart failure and chronic heart conditions: Expert opinion
by: Ahmet Çelik, et al.
Published: (2018) -
2016 ESC and ACC/AHA/HFSA heart failure guideline updates: Changes, similarities, differences, and unresolved isssues
by: İbrahim Sarı, et al.
Published: (2016) -
Snapshot evaluation of heart failure in Turkey: Baseline characteristics of SELFIE-TR
by: Mehmet Birhan Yılmaz, et al.
Published: (2019) -
Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study
by: Mehdi Zoghi, et al.
Published: (2016)